Direct patent infringement – CAR-T cells, Introduction

In the previous topic, you learned about direct infringement. Here, we’ll take a closer look at a novel cancer treatment in which the patient’s white blood cells are isolated, genetically modified, and then returned to the patient.

Please login or signup for this course to get access.

Register lost password

Glossary

Close course

Glossary

Support

Tools